Halozyme Therapeutics Market Sentiment

Halozyme Therapeutics Inc

HALONASDAQ

Trade with Public

$125.63

1.090.88%

마지막 업데이트: Oct 23, 6:50 PM

개요 뉴스 실적 전망 이벤트 목표가 재무심리지분 현황 비교 옵션 주식 보고서

실적: Q3 2026 실적이 목 11월 5th에 시장 마감 후 11일 후 후에 발표됩니다.

Halozyme Therapeutics Market Sentiment - Benzinga

Halozyme Therapeutics Market Sentiment

Market sentiment signals for Halozyme Therapeutics (HALO): analyst consensus, short interest, options flow and insider activity.

Key Signals

Analyst Consensus— Market Outperform

Short Interest▼ 17.7% short float

Options Flow▲ 0.18 P/C ratio

Insider Activity▼ Net Seller (30d)

Analyst Consensus

Market Outperform

16 analysts

Options Flow (P/C)

0.18

More calls — Bullish

248 calls · 45 puts

Avg Consensus PT

$86

-31.1%

Highest Price Target

$130

+4.4%

HC Wainwright & Co.

Lowest Price Target

$47

-62.3%

Leerink Partners

Short Interest

17.7%

Rising — Bearish

Insider Activity (30d)

Net Seller

Short Interest — % of Float

Recent Analyst Actions

Date	Firm	Analyst & Accuracy	Upside / Downside	PT Change	Action	Rating
Oct 13, 2026	TD Cowen	Brendan Smith—	+4.4%	$105 → $130	Maintained	Buy
Oct 8, 2026	JP Morgan	Jessica Fye—	-37.4%	$70 → $78	Maintained	Neutral
Oct 8, 2026	HC Wainwright & Co.	Mitchell S. Kapoor—	+4.4%	$115 → $130	Maintained	Buy
Sep 2, 2026	HC Wainwright & Co.	Mitchell S. Kapoor—	-7.7%	$115 → $115	Maintained	Buy
Aug 7, 2026	Leerink Partners	David Risinger—	-11.7%	$83 → $110	Upgrade	Market Perform→Outperform
Aug 7, 2026	TD Cowen	Brendan Smith—	-15.7%	$96 → $105	Maintained	Buy
Aug 7, 2026	Citizens	Jason N. Butler—	-25.3%	$92 → $93	Maintained	Market Outperform
Aug 7, 2026	Wells Fargo	Mohit Bansal—	-23.7%	$75 → $95	Maintained	Equal-Weight
Aug 7, 2026	HC Wainwright & Co.	Mitchell S. Kapoor—	-7.7%	$95 → $115	Maintained	Buy
Jul 21, 2026	HC Wainwright & Co.	Mitchell S. Kapoor—	-23.7%	$95 → $95	Maintained	Buy
May 12, 2026	Morgan Stanley	Vikram Purohit—	-25.3%	$96 → $93	Maintained	Overweight
Apr 29, 2026	HC Wainwright & Co.	Mitchell S. Kapoor—	-23.7%	$90 → $95	Maintained	Buy
Feb 19, 2026	Benchmark	Robert Wasserman—	-27.8%	$75 → $90	Maintained	Buy
Feb 19, 2026	Wells Fargo	Mohit Bansal—	-39.8%	$65 → $75	Maintained	Equal-Weight
Jan 8, 2026	TD Cowen	Brendan Smith—	-27.8%	$79 → $90	Maintained	Buy
Dec 19, 2025	HC Wainwright & Co.	Mitchell S. Kapoor—	-27.8%	$90 → $90	Maintained	Buy
Nov 28, 2025	HC Wainwright & Co.	Mitchell S. Kapoor—	-27.8%	$90 → $90	Maintained	Buy
Nov 18, 2025	Goldman Sachs	Graig Suvannavejh—	-55.0%	$54 → $56	Maintained	Neutral
Nov 4, 2025	Citizens	Jason Butler—	-26.2%	$91 → $92	Maintained	Market Outperform
Oct 27, 2025	JP Morgan	Jessica Fye—	-47.8%	$63 → $65	Maintained	Neutral
Oct 20, 2025	Morgan Stanley	Vikram Purohit—	-36.6%	$80 → $79	Maintained	Overweight
Oct 15, 2025	HC Wainwright & Co.	Mitchell S. Kapoor—	-27.8%	$90 → $90	Maintained	Buy
Oct 14, 2025	Leerink Partners	David Risinger—	-43.8%	$70	Upgrade	Underperform→Market Perform
Oct 2, 2025	HC Wainwright & Co.	Mitchell S. Kapoor—	-27.8%	$85 → $90	Maintained	Buy
Sep 24, 2025	Benchmark	Robert Wasserman—	-27.8%	$75 → $90	Maintained	Buy